IEZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 467
EU - Europa 387
AS - Asia 217
SA - Sud America 23
AF - Africa 1
Totale 1.095
Nazione #
US - Stati Uniti d'America 464
CN - Cina 73
SG - Singapore 69
UA - Ucraina 67
SE - Svezia 53
IE - Irlanda 52
FR - Francia 51
IT - Italia 48
GB - Regno Unito 45
TR - Turchia 44
DE - Germania 26
IN - India 24
BR - Brasile 22
FI - Finlandia 20
RU - Federazione Russa 10
BE - Belgio 7
HK - Hong Kong 4
CZ - Repubblica Ceca 3
AT - Austria 1
CA - Canada 1
CR - Costa Rica 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
VE - Venezuela 1
Totale 1.095
Città #
Chandler 91
Jacksonville 66
Dublin 52
Singapore 49
Ann Arbor 44
Ashburn 28
New York 26
Southend 26
Princeton 22
Izmir 20
The Dalles 19
Chieti 18
Beijing 13
Nanjing 12
Wilmington 12
Cambridge 11
Woodbridge 11
Altamura 10
Nanchang 10
Dearborn 9
Washington 9
Brussels 7
Santa Clara 7
Boardman 6
Kunming 6
Los Angeles 6
Munich 6
Tianjin 5
Turku 5
Grevenbroich 4
Hefei 4
Helsinki 4
Hong Kong 4
Foggia 3
Hangzhou 3
Hebei 3
Moscow 3
Pescara 3
San Mateo 3
Auburn Hills 2
Belo Horizonte 2
Brno 2
Curitiba 2
Guangzhou 2
Hanover 2
Lanzhou 2
Nova Iguaçu 2
Rio de Janeiro 2
Rome 2
San Salvo 2
Seattle 2
Tortoreto 2
Apodaca 1
Atlanta 1
Baghdad 1
Buffalo 1
Chongqing 1
El Tigre 1
Feira de Santana 1
Getafe 1
Harbin 1
Heredia 1
Imperatriz 1
Jiaxing 1
Jinan 1
Leawood 1
Marabá Municipality 1
Milan 1
Mogi Guaçu 1
Morro Agudo 1
Mumbai 1
Nairobi 1
Nanning 1
Nanyang 1
Ningbo 1
Norwalk 1
Nuremberg 1
Orange 1
Paris 1
Pedreiras 1
Penne 1
Pirapora do Bom Jesus 1
Pontedera 1
Prague 1
Recife 1
Richmond 1
Rio Branco 1
San Francisco 1
Shenyang 1
Shijiazhuang 1
São José do Rio Preto 1
São Paulo 1
São Sebastião do Paraíso 1
Taizhou 1
Tokyo 1
Uberlândia 1
Ubá 1
Vienna 1
Warsaw 1
Zhengzhou 1
Totale 714
Nome #
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 125
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 122
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 109
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 107
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 107
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 104
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 102
Association between 5-lipoxygenase expression and plaque instability in humans. 98
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 86
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 79
COX-2: friend or foe? 75
Totale 1.114
Categoria #
all - tutte 4.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202192 12 0 14 1 8 20 2 0 13 13 1 8
2021/202268 3 1 2 12 6 2 4 1 6 8 8 15
2022/2023220 15 34 12 33 25 41 8 8 34 2 5 3
2023/2024124 5 3 13 1 9 57 20 3 3 3 0 7
2024/2025188 14 34 20 5 8 12 2 4 21 20 40 8
Totale 1.114